ESGO Gynae-Oncology Guidelines – ESGO Gynaecological Oncology Guidelines

Publications

ESGO Vulvar cancer guidelines update 2023

ESGO/ESTRO/SIOPe Guidelines for the management of patients with vaginal cancer

ESGO/ESTRO/ESP Cervical cancer guidelines update 2023

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

ESGO/ESTRO Quality indicators of radiation therapy of cervical cancer

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial cancer

ESGO Guidelines on Peri-operative Management of Advanced Ovarian Cancer Patients Undergoing Debulking Surgery

New ESGO/ISUOG/IOTA/ESGE Consensus Statement on Pre-Operative Diagnosis of Ovarian Tumours Now Released on IJGC!

ESGO Guidelines on quality indicators for the surgical treatment of endometrial carcinoma

ESGO-GCIG Rare Tumours Algorithms in Mobile APP

AVAILABLE IN THE APP!

  • Cervical adenocarcinoma
  • High-Grade Endometrial & Undifferentiated Uterine Sarcoma
  • Small Cell Neuroendocrine Carcinoma of the Cervix
  • Borderline ovarian tumours
  • Ovarian carcinoid tumour
  • Ovarian small cell carcinoma
  • Ovarian teratoma
  • Ovarian sex cord - stromal tumours
  • Ovarian germ cell tumours of the ovary
  • Ovarian mucinous carcinoma
  • Ovarian low-grade serous carcinoma
  • Ovarian clear cell carcinoma
  • Vulvar & vaginal rare tumours

UPLOAD THE ESGO MOBILE GUIDE HERE:

Giudelines_mobileApp

ESGO Pocket Guidelines

Designed & Reviewed by Leading Experts to Advance Standards of Care and Practice

ESGO`s Annual Congress 2025

Register Now!

June 2024 - Registration opens

December 3, 2024 - Early-bird registration savings end

February 3, 2025 - Standard registration fee closes

Call for Abstracts key dates:

June 2024 - Abstract submissions opens

October 28, 2024 - Abstract submissions close (including late-breaking abstracts´ placeholders)

January 15, 2025 - Late-breaking abstract submissions close